Human UCN2/SRP/UCN-II ORF/cDNA clone-Lentivirus particle (NM_033199)
Cat. No.: vGMLP000406
Pre-made Human UCN2/SRP/UCN-II Lentiviral expression plasmid for UCN2 lentivirus packaging, UCN2 lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.
The GM Vector Core (GMVC) specializes in custom lentivirus development and offers a range of lentivirus manufacturing solutions, leveraging state-of-the-art processes. Learn more about our services.
Go to
UCN2/SRP products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
| Catalog No. | Product Name | lentivirus Grade | lentivirus quantity |
|---|---|---|---|
| vGMLP000406 | Human UCN2 Lentivirus particle | Pilot Grade | 1.0E+8TU |
| 5.0E+8TU | |||
| 1.0E+9TU | |||
| Research Grade | 1.0E+8TU | ||
| 5.0E+8TU | |||
| 1.0E+9TU | |||
| GMP-like Grade | inquiry | ||
| GMP Grade | inquiry |
Product Description
| Catalog ID | vGMLP000406 |
| Gene Name | UCN2 |
| Accession Number | NM_033199 |
| Gene ID | 90226 |
| Species | Human |
| Product Type | Lentivirus particle (overexpression) |
| Insert Length | 339 bp |
| Gene Alias | SRP,UCN-II,UCNI,UR,URP |
| Fluorescent Reporter | ZsGreen |
| Mammalian Cell Selection | Puromyocin |
| Fusion Tag | 3xflag (C-Terminal) |
| Promoter | CMV |
| Resistance | Amplicin |
| ORF Nucleotide Sequence | ATGACCAGGTGTGCTCTGCTGTTGCTGATGGTCCTGATGTTGGGCAGAGTCCTGGTTGTCCCAGTGACCCCTATCCCAACCTTCCAGCTCCGCCCTCAGAATTCTCCCCAGACCACTCCCCGACCTGCGGCCTCAGAGAGCCCCTCAGCTGCTCCCACATGGCCGTGGGCTGCCCAGAGCCACTGCAGCCCCACCCGCCACCCTGGCTCGCGCATTGTCCTATCGCTGGATGTCCCCATCGGCCTCTTGCAGATCTTACTGGAGCAAGCCCGGGCCAGGGCTGCCAGGGAGCAGGCCACCACCAACGCCCGCATCCTGGCCCGTGTCGGCCACTGCTGA |
| ORF Protein Sequence | MTRCALLLLMVLMLGRVLVVPVTPIPTFQLRPQNSPQTTPRPAASESPSAAPTWPWAAQSHCSPTRHPGSRIVLSLDVPIGLLQILLEQARARAAREQATTNARILARVGHC |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
| Category | Cat No. | Products Name |
|---|---|---|
| Target Antibody | GM-Tg-g-SE0533-Ab | Anti-UCN2/ SRP/ UCN-II functional antibody |
| Target Antigen | GM-Tg-g-SE0533-Ag | UCN2 protein |
| ORF Viral Vector | pGMLP000406 | Human UCN2 Lentivirus plasmid |
| ORF Viral Vector | vGMLP000406 | Human UCN2 Lentivirus particle |
Target information
| Target ID | GM-SE0533 |
| Target Name | UCN2 |
|
Gene Group Identifier (Target Gene ID in Homo species) |
90226 |
| Gene ID |
100683848 (Canis lupus familiaris), 101088991 (Felis catus), 106996925 (Macaca mulatta), 138918041 (Equus caballus) 170896 (Rattus norvegicus), 171530 (Mus musculus), 751828 (Bos taurus), 90226 (Homo sapiens) |
| Gene Symbols & Synonyms | UCN2,Ucn2,Ucn3,Ucn-2,Ucn II,ucn-II,UR,SRP,URP,UCNI,UCN-II |
| Target Alternative Names | SRP,Stresscopin-related peptide,UCN-II,UCN2,UCNI,UR,URP,Ucn II,Ucn-2,Ucn2,Ucn3,Urocortin II (Ucn II),Urocortin-2,Urocortin-related peptide,ucn-II |
| Uniprot Accession |
Q91WW1,Q96RP3,Q99ML8
Additional SwissProt Accessions: Q91WW1,Q99ML8,Q96RP3 |
| Uniprot Entry Name | |
| Protein Sub-location | Secreted Protein/Potential Cytokines |
| Category | |
| Disease | |
| Disease from KEGG | Neuroactive ligand-receptor interaction |
| Gene Ensembl | ENSMMUG00000059318, ENSMUSG00000049699, ENSBTAG00000019078, ENSG00000145040 |
| Target Classification |
About GMVC

GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.


